Drug Profile
PW 4153
Alternative Names: Levodopa/carbidopa extended-release - Penwest; PW-4153Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Penwest Pharmaceuticals
- Class Antiasthmatics; Antiparkinsonians; Aromatic amino acids; Catecholamines; Hydrazines; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 04 Nov 2008 Discontinued - Phase-I for Parkinson's disease in USA (PO)
- 21 Jul 2008 Phase-I clinical trials in Parkinson's disease in USA (PO)